drugset / Trial / NCT03047330

Menopausal Sleep Fragmentation and Body Fat Gain

NCT03047330

NaSingle-groupOpen-labelBasic science

Summary

This study aims to investigate the impact of menopause-related sleep fragmentation on metabolic biomarkers of body fat gain. The investigators hypothesize that experimental sleep fragmentation will result in an adverse leptin response as a metabolic biomarker for body fat gain.

Timeline

Start
2017-07-15
Primary completion
2022-08-01
Completion
2022-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Leuprolide Other / unclassified 3.75 mg

Indications

No indication recorded.